1. Home
  2. PRME vs ASA Comparison

PRME vs ASA Comparison

Compare PRME & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • ASA
  • Stock Information
  • Founded
  • PRME 2019
  • ASA 1958
  • Country
  • PRME United States
  • ASA United States
  • Employees
  • PRME N/A
  • ASA N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • ASA Precious Metals
  • Sector
  • PRME Health Care
  • ASA Industrials
  • Exchange
  • PRME Nasdaq
  • ASA Nasdaq
  • Market Cap
  • PRME 693.5M
  • ASA 697.1M
  • IPO Year
  • PRME 2022
  • ASA N/A
  • Fundamental
  • Price
  • PRME $4.67
  • ASA $41.12
  • Analyst Decision
  • PRME Buy
  • ASA
  • Analyst Count
  • PRME 6
  • ASA 0
  • Target Price
  • PRME $8.88
  • ASA N/A
  • AVG Volume (30 Days)
  • PRME 2.9M
  • ASA 162.0K
  • Earning Date
  • PRME 11-11-2025
  • ASA 09-30-2025
  • Dividend Yield
  • PRME N/A
  • ASA 0.14%
  • EPS Growth
  • PRME N/A
  • ASA 331.75
  • EPS
  • PRME N/A
  • ASA 14.01
  • Revenue
  • PRME $4,961,000.00
  • ASA $3,923,667.00
  • Revenue This Year
  • PRME $179.58
  • ASA N/A
  • Revenue Next Year
  • PRME N/A
  • ASA N/A
  • P/E Ratio
  • PRME N/A
  • ASA $2.96
  • Revenue Growth
  • PRME 739.42
  • ASA 66.52
  • 52 Week Low
  • PRME $1.11
  • ASA $19.37
  • 52 Week High
  • PRME $5.17
  • ASA $41.89
  • Technical
  • Relative Strength Index (RSI)
  • PRME 67.60
  • ASA 73.13
  • Support Level
  • PRME $3.09
  • ASA $39.81
  • Resistance Level
  • PRME $4.18
  • ASA $41.89
  • Average True Range (ATR)
  • PRME 0.31
  • ASA 0.88
  • MACD
  • PRME 0.11
  • ASA 0.20
  • Stochastic Oscillator
  • PRME 98.14
  • ASA 85.75

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About ASA ASA Gold and Precious Metals Limited

ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.

Share on Social Networks: